Shi S - Search Results

1

Monoclonal Antibody against CXCL1 (HL2401) as a Novel Agent in Suppressing IL6 Expression and Tumoral Growth.

Miyake M, Furuya H, Onishi S, Hokutan K, Anai S, Chan O, Shi S, Fujimoto K, Goodison S, Cai W, Rosser CJ. Miyake M, et al. Among authors: shi s. Theranostics. 2019 Jan 25;9(3):853-867. doi: 10.7150/thno.29553. eCollection 2019. Theranostics. 2019. PMID: 30809313 Free PMC article.

2

Biomedical applications of functionalized hollow mesoporous silica nanoparticles: focusing on molecular imaging.

Shi S, Chen F, Cai W. Shi S, et al. Nanomedicine (Lond). 2013 Dec;8(12):2027-39. doi: 10.2217/nnm.13.177. Nanomedicine (Lond). 2013. PMID: 24279491 Free PMC article. Review.

3

Generation and screening of monoclonal antibodies for immunoPET imaging of IGF1R in prostate cancer.

Hong H, Nayak TR, Shi S, Graves SA, Fliss BC, Barnhart TE, Cai W. Hong H, et al. Among authors: shi s. Mol Pharm. 2014 Oct 6;11(10):3624-30. doi: 10.1021/mp5003637. Epub 2014 Sep 4. Mol Pharm. 2014. PMID: 25157758 Free PMC article.

4

VEGF₁₂₁-conjugated mesoporous silica nanoparticle: a tumor targeted drug delivery system.

Goel S, Chen F, Hong H, Valdovinos HF, Hernandez R, Shi S, Barnhart TE, Cai W. Goel S, et al. Among authors: shi s. ACS Appl Mater Interfaces. 2014 Dec 10;6(23):21677-85. doi: 10.1021/am506849p. Epub 2014 Nov 10. ACS Appl Mater Interfaces. 2014. PMID: 25353068 Free PMC article.

5

In vivo tumor targeting and image-guided drug delivery with antibody-conjugated, radiolabeled mesoporous silica nanoparticles.

Chen F, Hong H, Zhang Y, Valdovinos HF, Shi S, Kwon GS, Theuer CP, Barnhart TE, Cai W. Chen F, et al. Among authors: shi s. ACS Nano. 2013 Oct 22;7(10):9027-39. doi: 10.1021/nn403617j. Epub 2013 Oct 1. ACS Nano. 2013. PMID: 24083623 Free PMC article.

6

Surface engineering of graphene-based nanomaterials for biomedical applications.

Shi S, Chen F, Ehlerding EB, Cai W. Shi S, et al. Bioconjug Chem. 2014 Sep 17;25(9):1609-19. doi: 10.1021/bc500332c. Epub 2014 Aug 18. Bioconjug Chem. 2014. PMID: 25117569 Free PMC article. Review.

7

PET of follicle-stimulating hormone receptor: broad applicability to cancer imaging.

Hong H, Yan Y, Shi S, Graves SA, Krasteva LK, Nickles RJ, Yang M, Cai W. Hong H, et al. Among authors: shi s. Mol Pharm. 2015 Feb 2;12(2):403-10. doi: 10.1021/mp500766x. Epub 2015 Jan 20. Mol Pharm. 2015. PMID: 25581441 Free PMC article.

8

Dual Targeting of Tissue Factor and CD105 for Preclinical PET Imaging of Pancreatic Cancer.

Luo H, England CG, Shi S, Graves SA, Hernandez R, Liu B, Theuer CP, Wong HC, Nickles RJ, Cai W. Luo H, et al. Among authors: shi s. Clin Cancer Res. 2016 Aug 1;22(15):3821-30. doi: 10.1158/1078-0432.CCR-15-2054. Epub 2016 Mar 29. Clin Cancer Res. 2016. PMID: 27026197 Free PMC article.

9

Evaluation of the biological activities of the IL-15 superagonist complex, ALT-803, following intravenous versus subcutaneous administration in murine models.

Liu B, Jones M, Kong L, Noel T, Jeng EK, Shi S, England CG, Alter S, Miller JS, Cai W, Rhode PR, Wong HC. Liu B, et al. Among authors: shi s. Cytokine. 2018 Jul;107:105-112. doi: 10.1016/j.cyto.2017.12.003. Epub 2018 Feb 13. Cytokine. 2018. PMID: 29452720 Free PMC article.

10

ImmunoPET of CD38 with a radiolabeled nanobody: promising for clinical translation.

Shi S, Goel S, Lan X, Cai W. Shi S, et al. Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):2683-2686. doi: 10.1007/s00259-021-05329-9. Eur J Nucl Med Mol Imaging. 2021. PMID: 33942140 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,643 results

Search Page

Filters